Xenon Pharmaceuticals Inc. Quarterly Operating Lease, Payments in USD from Q1 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Xenon Pharmaceuticals Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2018 to Q1 2024.
  • Xenon Pharmaceuticals Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $411K, a 1.23% increase year-over-year.
  • Xenon Pharmaceuticals Inc. annual Operating Lease, Payments for 2023 was $1.62M, a 76.7% increase from 2022.
  • Xenon Pharmaceuticals Inc. annual Operating Lease, Payments for 2022 was $919K, a 11.5% increase from 2021.
  • Xenon Pharmaceuticals Inc. annual Operating Lease, Payments for 2021 was $824K, a 30% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $411K +$5K +1.23% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $406K +$203K +100% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $203K +$1K +0.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $202K +$43K +27% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $159K +$1K +0.63% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q1 2019 $158K +$6K +3.95% Jan 1, 2019 Mar 31, 2019 10-Q/A 2020-05-26
Q1 2018 $152K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.